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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYCyclic activationof theWnt/b-catenin signalingpathwaycontrols cell fusion-mediated somatic cell reprogramming. TCFs belong to a fam-
ily of transcription factors that, in complexwith b-catenin, bind and transcriptionally regulateWnt target genes. Here, we show thatWnt/
b-catenin signaling needs to be off during the early reprogramming phases of mouse embryonic fibroblasts (MEFs) into iPSCs. In MEFs
undergoing reprogramming, senescence genes are repressed and mesenchymal-to-epithelial transition is favored. This is correlated with
a repressive activity of TCF1, which contributes to the silencing of Wnt/b-catenin signaling at the onset of reprogramming. In contrast,
theWnt pathwayneeds to be active in the late reprogrammingphases to achieve successful reprogramming. In conclusion, continued acti-
vationor inhibition of theWnt/b-catenin signalingpathway is detrimental to the reprogrammingofMEFs; instead, temporal perturbation
of the pathway is essential for efficient reprogramming, and the ‘‘Wnt-off’’ state can be considered an early reprogramming marker.INTRODUCTION
The activation of canonical Wnt/b-catenin pathway con-
trols embryo development and early differentiation events
(MacDonald et al., 2009). However, it can also control the
self-renewal and pluripotency of stem cells (Ku¨hl and
Ku¨hl, 2013; Sato et al., 2004; Sokol, 2011). The activation
of this pathway is due to the inhibition of the b-catenin
destruction complex formed by APC, GSK3, and AXIN, re-
sulting in b-catenin stabilization. Consequently, b-catenin
can then translocate into the nucleus and activate target
genes via its association with the TCF factors (Cadigan
and Liu, 2006; Hoppler and Kavanagh, 2007; Moon et al.,
2004). TCF proteins belong to a family of transcription
factors, which include TCF1, LEF1, TCF3, and TCF4.
TCF1 and LEF1 can bind b-catenin and activate target genes
when the Wnt pathway is active (Hoppler and Kavanagh,
2007; Hurlstone and Clevers, 2002; Willert and Jones,
2006). In contrast, when the Wnt pathway is not active,
all the TCF factors can recruit repressive complexes and
function as repressors of target genes (Brantjes et al.,
2001; Daniels and Weis, 2005).
Embryonic stem cells (ESCs) cultured in 2i medium,
which contains GSK3 and MEK inhibitors, can be propa-
gated in a pluripotent ground state (Silva et al., 2008).
Pluripotent ground state is also established byTcf3 deletion
in ESCs (Cole et al., 2008; Tam et al., 2008; Wray et al.,
2011; Yi et al., 2008, 2011). It is interesting to note that
the GSK3 inhibitor in 2i medium stabilizes b-catenin.
This suggests that the pluripotent ground state of ESCsStecan be maintained by derepression of TCF3 but also by
activation of the Wnt pathway via stabilization of
b-catenin. Moreover, activation of Wnt signaling prevents
differentiation of ESCs into epiblast stem cells (epiSCs),
through regulation of the transition between the ground
and primed states (ten Berge et al., 2011).
The Wnt/b-catenin pathway can also activate somatic
cell reprogramming to pluripotency. Mouse embryonic
fibroblasts (MEFs) transduced with retroviruses carrying
Oct4, Klf4, and Sox2 and cultured in medium containing
Wnt3a can generate induced pluripotent stem cell (iPSC)
colonies with enhanced efficiency in absence of c-Myc
(Marson et al., 2008). Furthermore, activation of the Wnt
pathway in ESCs enables them to reprogram neural precur-
sor cells after fusion (Lluis et al., 2008). Finally, the deletion
of Tcf3 greatly enhances cell-fusion-mediated reprogram-
ming, as well as the production of induced pluripotent
stem cells (iPSCs) (Lluis et al., 2011; Ombrato et al., 2012).
In addition to the Wnt-mediated control of ESC pluripo-
tency and somatic cell reprogramming, Wnt signaling is
also a driver of differentiation during early developmental
phases (Tam and Loebel, 2009). Anterior-posterior axis
specification in the mouse embryo occurs through the
activity of Wnt signaling (Merrill et al., 2004; Sokol,
2011). In particular, Wnt signaling activity is essential for
establishment of the primitive streak and anterior-
posterior polarity, i.e., for epithelial-to-mesenchymal tran-
sition of epiblast cells in the primitive streak (Kalluri and
Weinberg, 2009; Murry and Keller, 2008; Tanaka et al.,
2011; ten Berge et al., 2008).m Cell Reports j Vol. 2 j 707–720 j May 6, 2014 j ª2014 The Authors 707
Stem Cell Reports
Reprogramming via Time-Dependent Wnt/TCF1 ActivityThese apparently opposite roles of the Wnt signaling
pathway are therefore a conundrum; on one hand, Wnt
activity controls ESC pluripotency, and on the other
hand, it regulates early developmental differentiation
events. To reconcile these opposite functions, one reason-
able hypothesis is based on the level of activation of the
Wnt pathway in time. It is well known that Wnt signaling
oscillates during development and that its target genes
have an oscillatory behavior (Sokol, 2011; van Amerongen
and Nusse, 2009). At the same time, cyclic activation of the
Wnt/b-catenin pathway is essential for enhancing somatic
cell reprogramming (Lluis and Cosma, 2009; Lluis et al.,
2008). If b-catenin activity is either high or very low, re-
programming does not take place. We therefore wondered
whether the activation of Wnt signaling activity mediated
by TCF factors is essential in a specific phase of the reprog-
ramming of MEFs into iPSCs.
TCF3 and TCF1 share a similar DNA binding domain,
and they represent the most highly expressed TCF family
factors in ESCs (Lluis et al., 2011; Pereira et al., 2006).
TCF3 acts as a repressor ofWnt target genes, and in contrast
TCF1 can activate or repress Wnt-targets via its association
with b-catenin (Brantjes et al., 2001; Hikasa et al., 2010).
However, little is known about TCF1 function in ESCs,
and here we investigated the role of TCF1 in the reprogram-
ming process of MEFs into iPSCs. Surprisingly, in this
context, we found that the activity of the Wnt/b-catenin
pathway needs to be switched off during the first days
and that the cells undergoing reprogramming have low
levels of stabilized b-catenin. Remarkably, sorted Wnt
‘‘off’’ MEFs generate a very high number of NANOG-
positive iPSCs. Interestingly, during the early phases of
four-factor-induced reprogramming, TCF1 functions as a
repressor of Wnt signaling, and this activity correlates
with downregulation of senescent genes, such as p21,
p19, and p16, and activation of mesenchymal-to-epithelial
transition (MET) genes. The activity of the Wnt/b-catenin
pathway is instead necessary during the late phases of the
reprogramming process.RESULTS
TCF1 Does Not Control Self-Renewal or
Differentiation of ESCs
TCF3 is a repressor of pluripotency in ESCs, and its deletion
drives the ESCs into a pluripotent ground state (Wray et al.,
2011; Yi et al., 2011). Silencing of Tcf1 does not affect ESC
self-renewal (Yi et al., 2011). Here, we investigated whether
TCF1 has a role in controlling mouse ESC differentiation.
With this aim, we silenced Tcf1 in ESCs by infecting the
cells with two different lentiviral vectors that carry short
hairpins for Tcf1 (ESCs-shTcf1A, ESCs-shTcf1B) (Figures708 Stem Cell Reports j Vol. 2 j 707–720 j May 6, 2014 j ª2014 The AuthorsS1A and S1B available online) and observed that Wnt
signaling activity was impaired (Figure S1C). The Wnt
signaling activity was measured after activating the
pathway with the GSK3 inhibitor BIO in ESCs-shTcf1A,
ESCs-shTcf1B, and ESCs-shScr, which were previously in-
fected with a lentivirus carrying the 7xTcf-eGFP reporter
(7TGP) for TCF/b-catenin activity (Figure S1C) (Fuerer
and Nusse, 2010). The reporter allowed the measurement
of GFP as a Wnt signaling activation readout (Fuerer and
Nusse, 2010). The viruses carrying the short hairpins also
carried a hygromicin selection cassette, to allow the selec-
tion of the infected cells. Then we analyzed the expression
of stem cell genes and self-renewal in ESCs-shTcf1A and
ESCs-shTcf1B (Figure 1A). Expression of Nanog, Stella, and
Oct4 was not decreased after silencing of Tcf1, with respect
to cells infected with a virus carrying a scrambled short
hairpin (ESCs-shScr), which indicated that the expression
of stem cell factors was not affected (Figure 1A). Finally,
we performed clonogenic assays by culturing the same
number of ESCs infected with shTcf1A, shTcf1B, and shScr
and counting the number of alkaline-phosphatase-positive
(AP+) colonies, as a marker of pluripotency. The same num-
ber of colonies was counted under all three conditions, and
their morphologies were indistinguishable (Figure 1B).
Next, we analyzed the possible defects in the differentia-
tion potential of ESCs silenced for Tcf1. For this, we gener-
ated embryoid bodies using ESCs-shScr, ESCs-shTcf1A, and
ESCs-shTcf1B. We analyzed the expression of pluripotent
genes and of mesoderm, ectoderm, and endodermmarkers
at 3, 5, 7, and 9 days during embryoid body development.
Embryoid bodies from both ESCs-shScr and ESCs-shTcf1A
developedwith the expectedmorphology at all time points
analyzed (Figure 1C). Pluripotency genes, such as Oct4,
Nanog, and Rex1, decreasedwith the same efficiency and ki-
netics in both the ESCs-shScr and ESCs-shTcf1A embryoid
bodies. Furthermore, the mesoderm markers Brachyury
and Flk1, the ectoderm markers Fgf5 and Pax6, and the
endoderm markers Gata4 and Foxa2 were expressed with
the expected timing at 3, 5, 7, and 9 days of both ESCs-
shScr and ESCs-shTcf1A embryoid body development (Fig-
ure 1D). Comparable efficiency of the differentiation
potential was also obtained after analyzing the expression
of pluripotent genes and of the mesoderm, ectoderm, and
endoderm markers during embryoid body development
for ESCs-shScr and ESCs-shTcf1B (Figures S1D and S1E).
In all, these data clearly show that silencing of Tcf1 in
mouse ESCs impairs neither self-renewal nor differentia-
tion potential.
Continuous Tcf1 Silencing Impairs Reprogramming
of MEFs to Pluripotency
Previous studies, including our own, have shown that the
activation of Wnt signaling enhances cell-fusion-mediated
A B
C D
Figure 1. Silencing of Tcf1 in Mouse ESCs Does Not Affect Pluripotency
(A) Quantitative PCR expression analysis of pluripotent markers Nanog, Stella, and Oct4 in ESCs infected with lentiviruses carrying shScr or
shTcf1A/B, as indicated. (n = 3, independent experiments).
(B) Representative colonies of ESCs-shScr and ESCs-shTcf1A/B showing alkaline phosphatase staining (left panels). Quantification on the
right shows percentages of alkaline-phosphatase-positive (AP+) colonies with respect to all (AP+ and AP) colonies (n = 3 independent
experiments). Scale bar, 300 mm.
(C) ESCs-shScr and ESCs-shTcf1A were subjected to differentiation through aggregation into embryoid bodies. Representative phase-
contrast images at 3, 5, 7, and 9 days during embryoid body differentiation. Scale bar, 400 mm.
(D) Representative quantitative real-time PCR experiment (out of three independent experiments) for the detection of Tcf1, stem cell
(Oct-4, Nanog, and Rex1), ectoderm (Fgf5, Pax6), mesoderm (Brachyury, Flk1), and endoderm (Gata4 and Foxa2) marker genes in embryoid
bodies at different times pi. The levels are normalized to Gapdh.
All pooled data are represented as means ± SD. See also Figure S1.
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efficiency of generation of iPSCs in the absence of c-Myc
(Lluis et al., 2008; Marson et al., 2008). Furthermore, dere-
pression of Tcf3 greatly enhances the reprogramming effi-
ciency of neural precursor cells to pluripotency (Lluis
et al., 2011). We were next interested in studying the func-
tion of TCF1 in the control of somatic cell reprogramming.
In addition, because TCF1 controls target genes through itsSteassociation with b-catenin, in parallel, we investigated
b-catenin activity in the regulation of reprogramming.
Thus, we infected doxycycline-inducible four-factor
(Oct4, Klf4, Sox2, and c-Myc) MEFs (Carey et al., 2010)
with shTcf1A, with shTcf1B, with shb-catenin (shb-cat),
and with control shScr (Figures S2A and S2B). Infected
MEFs were selected with hygromycin, replated at equal
numbers, and subsequently induced with doxycycline form Cell Reports j Vol. 2 j 707–720 j May 6, 2014 j ª2014 The Authors 709
Figure 2. Silencing of Tcf1 in Four-
Factor-Induced MEFs Impairs Repro-
gramming
(A) Experimental scheme for iPSC genera-
tion. Four-factor MEFs were infected with
lentiviral vectors carrying shScr, shTcf1A,
and shb-catenin. Infected cells were
hygromycin selected for 3 days. Doxycycline
was applied from 0 to 12 days, to activate
expression of Oct4, Klf4, Sox2, and c-Myc.
Then doxycycline was removed, and cells
were allowed to grow for 4 days. At
day 16, immunostaining against NANOG
was performed, to count the number of re-
programmed clones.
(B) Number of NANOG-positive (NANOG+)
clones obtained according to each treat-
ment, as indicated (n = 4 independent ex-
periments).
(C) Representative image of a NANOG+ clone
obtained from shScr- and shTcf1-infected
MEFs analyzed at day 16.
(D) Images of immunostaining of iPSC clones obtained from four-factor MEFs infected with shScr. Scale bars, 200 mm (NANOG, OCT4, SSEA1,
and SOX2) and 500 mm (AP). Nuclei were stained with DAPI.
All pooled data are represented as means ± SD. The asterisks indicate statistical significance by t test analysis (n.s., not significant; *p <
0.05; **p < 0.01). See also Figure S2.
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4 days, and iPSC colonies were analyzed at day 16, by
counting the NANOG-positive (NANOG+) colonies (Fig-
ure 2A). The number of NANOG+ colonies was strongly
reduced after both Tcf1 and b-catenin silencing, with
respect to the control (Figures 2B, S2C, and S2D). Further-
more, the few colonies that were formed after Tcf1
silencing were very small and with little NANOG expres-
sion (Figure 2C). In contrast, shScr-derived iPSCs formed
with high efficiency, were positive to alkaline phosphatase
(AP), expressed stem cell markers (such as SSEA-1, NANOG,
OCT4, SOX2, Sall1, and Rex1), and differentiated into all
three germ layers (Figures 2D S2E, and S2F). Finally, to
exclude adaptation of the MEFs to the loss of Tcf1, we
infectedMEFs with shTcf1A and used doxycyline to induce
the four factors at the same time. Also, in this case, we
observed a decrease in the NANOG+ colonies, although
this effect was weaker, as the MEFs were not hygromycin
selected (Figure S2G). These data show that continuous
silencing of b-catenin orTcf1 for 16 days impairs reprogram-
ming efficiency.
Inhibition of the Wnt Pathway during the Early
Phases Enhances MEF Reprogramming via TCF1
Activity
As TCF1 did not appear to have any role in the mainte-
nance of ESC self-renewal, we hypothesized that TCF1
might control reprogramming onset, i.e., the early steps710 Stem Cell Reports j Vol. 2 j 707–720 j May 6, 2014 j ª2014 The Authorsof the process. Thus, we investigated Tcf1 expression at
different time points after doxycycline induction.
THY1 can be followed as an early marker of reprogram-
ming (Brambrink et al., 2008; Stadtfeld et al., 2008). Cells
negative for the expression of this marker 3 days after
four-factor induction are enriched in the population un-
dergoing reprogramming (Polo et al., 2012). So four-factor
MEFs were inducedwith doxycycline and sorted by fluores-
cence-activated cell sorting (FACS) 3, 6, and 9 days after in-
duction for the presence or absence of THY1 (Figures 3A
and S3A). Enrichment of Thy expression in sorted cells
was confirmed by real-time PCR (Figure S3B). Cells under-
going reprogramming embark into MET (Esteban et al.,
2012; Li et al., 2010; Samavarchi-Tehrani et al., 2010).
Thus, we analyzed expression of epidermal markers, Epcam
and Cdh1, and mesenchymal markers, Snai1, Slug, and
Vimentin (ten Berge et al., 2008).We observed, as previously
shown (Polo et al., 2012), that THY1-negative cells undergo
efficient MET, as they upregulated Epcam and Cdh1 and
downregulated Snai1, Slug, and Vimentin. In contrast,
THY1-positive cells maintained the mesenchymal pheno-
type (Figure 3B). In addition, the senescence genes p21,
p16, and p19, which have been shown to be a barrier to
the reprogramming of MEFs into iPSCs (Banito et al.,
2009; Hong et al., 2009; Kawamura et al., 2009; Li et al.,
2009; Mario´n et al., 2009; Utikal et al., 2009), were down-
regulated in the THY1-negative cells (Figure 3B). Finally,
the THY1-negative cells gave rise to fully reprogrammed
Stem Cell Reports
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(Figure 3C).
We found that, while in the THY1-negative cells, Tcf3
expression remained almost constant at all time points of
the reprogramming process, it increased from 6 to 9 days
in the THY1-positive cells. This indicates that as expected,
cells undergoing reprogramming indeed maintain low
levels of Tcf3, the repressor of pluripotency (Lluis et al.,
2011). In contrast, Tcf1 expression levels increased progres-
sively from 0 to 6 days in both THY1-positive and THY1-
negative cells, before decreasing again in both populations
9 days postinduction (pi) (Figure 3D).
Tcf1 has several isoforms, including full-length and DN
isoforms (FLTcf1 and DNTcf1, respectively), which have
been extensively studied (Reya and Clevers, 2005; Van de
Wetering et al., 1996). DNTCF1 was shown to be a
repressor, as it lacks the b-catenin binding domain (Roose
et al., 1999; Waterman, 2004). We therefore investigated
which Tcf1 isoform increases during reprogramming of
MEFs. FLTCF1 was greatly increased 6 days pi, as seen using
an antibody against FLTCF1 (Figure 3E). FLTCF1 is also the
isoform that is expressed in ESCs. In contrast, DNTCF1,
which is highly expressed in thymocytes (Ioannidis et al.,
2001; Yu et al., 2010), was not detected during the reprog-
ramming process (Figure 3E).
Although the expression profile of Tcf1was similar in the
THY1-positive and THY1-negative cells 6 days pi, the acti-
vation of the Wnt signaling pathway was different. Activa-
tion of the Wnt pathway, through analysis of the 7TGC
reporter activity (Fuerer and Nusse, 2010), was higher in
the THY1-positive cells with respect to the THY1-negative
cells (Figure 3F). Furthermore, expression of the Wnt/
b-catenin targets CyclinD1, Axin2, and BMP4 was increased
in the THY1-positive cells with respect to the THY1-nega-
tive cells, with a peak at 6 days pi (Figure 3G), indicating
thatWnt activity ismuchhigher in the THY1-positive cells,
which do not undergo reprogramming.
To confirm these observations, we analyzed b-catenin
levels in THY1-positive and THY1-negative cells at 6 days
pi. Here, active and total b-catenin accumulated more in
the THY1-positive cells, clearly indicating that b-catenin
can efficiently activate the pathway along with TCF1
in the THY1-positive cells only (Figures 3H and S3C). In
contrast, in the THY1-negative cells, Tcf1 appeared to act
as a repressor, as at 6 days postinduction, theWnt pathway
was inactive and b-catenin accumulated much less than in
the THY1-positive cells (Figure 3H). Indeed, when b-cate-
nin does not accumulate, TCF1 acts as a repressor, by bind-
ing to corepressor factors, such asmembers of theGroucho-
related family (Reya et al., 2003; Roose et al., 1998).
To further investigate the repressive activity of TCF1, we
overexpressed Tcf1 in MEFs and analyzed target genes. In
particular, for this purpose, we overexpressed FLTcf1,Stewhich increased during reprogramming, and as a control,
DNTcf1. Axin2 was drastically downregulated after both
DNTcf1 and FLTcf1 expression respect to the empty vector
(E.V.), which indicated that both isoforms repress the
Wnt signaling pathway (Figure 4A). The repressive activity
of TCF1 was converted into an activation of the Wnt
pathway when Chiron, a GSK3 inhibitor, or Wnt3a were
added to the FLTcf1 infected MEFs. Axin2 was upregulated
upon pathway activation (Figures S4A and S4B).
We observed that the mesenchymal genes Vim, Slug, and
Snai1 were downregulated by overexpression of both
isoforms of Tcf1 (Figure 4A). The senescence genes are upre-
gulated in ESCs that express very high levels of b-catenin,
resulting in an impairment of cell-fusion-mediated reprog-
ramming (Lluis et al., 2010). Therefore, we analyzed their
expression after Tcf1 upregulation. p21, p19, and p16
were all downregulated upon FLTcf1 and DNTcf1 overex-
pression (Figure 4A). In contrast, senescence genes and
Snai1 do not change in their expression when the Wnt
pathway is activated in shTcf1A-MEFs (Figure S4C). Finally,
to determine whether TCF1 directly regulates MET and
senescence genes, we performed chromatin immunopre-
cipitation (ChIP) assays in MEFs, which demonstrated
binding of TCF1 to Snai1, p21, and Axin2 promoters
(Figure 4B).
Overall, these data indicated that TCF1 can act as a
repressor of the Wnt/b-catenin pathway in MEFs, and
this results in the repression of some of the mesenchymal
and senescent genes.
Next, we investigated whether overexpression of Tcf1
increased the number of cells undergoing reprogramming.
Indeed, we observed a higher number of THY1-negative
cells 6 days after infection of four-factor MEFs, compared
to EV. (Figure 4C). Also, these cells showed downregulation
of Axin2 as well as the mesenchymal genes Vim, Snai1, and
Slug and the senescence markers p19 and p21 (Figure 4D).
Next, because Tcf1 increased 6 days pi, we investigated
further whether perturbation of Tcf1 at this time point
was essential in the reprogramming process. For this pur-
pose, we infected four-factor MEFs with shTcf1A, shTcf1B,
and shScr, selected with hygromycin, induced with doxy-
cycline, FACS sorted the THY1-negative cells 6 days after
induction, and plated these cells in equal numbers (Fig-
ure 4E). We observed a reduction in the number of
NANOG+ clones from the shTcf1-infected MEFs when
compared to the control (Figures 4F and S4D). This shows
that silencing the repressive activity of Tcf1 in THY1-nega-
tive cells inhibits the reprogramming process.
To determine whether this effect was dependent on the
activation of the MET and/or senescence genes, we
analyzed gene expression 6 days after induction in the
THY1-negative cells. Interestingly, there was an upregula-
tion of themesenchymal gene Snai1 and a downregulationm Cell Reports j Vol. 2 j 707–720 j May 6, 2014 j ª2014 The Authors 711
(legend on next page)
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over, p21 and p16were upregulated 6 days pi in the shTcf1-
infected MEFs (Figure 4G). These data indicate that
silencing the repressive activity of TCF1 in the THY1-nega-
tive cells in the early phases of reprogramming blocks MET
and increases senescence barrier.
Wnt ‘‘Off’’ State Is an Early Reprogramming Marker
To further monitor whetherWnt ‘‘off’’ cells in early reprog-
ramming phases embark upon efficient reprogramming,
we infected four-factor MEFs with a lentivirus carrying
the 7xTcf-eGFP reporter (7TGC) for TCF/b-catenin activity
and mCherry under the constitutive SV40 promoter (Fig-
ure S5A) (Fuerer and Nusse, 2010). Among the cells that
were mCherry positive, four populations of cells with
different GFP fluorescence levels were FACS sorted 6 days
after doxycycline induction (Figures 5A and S5B). Axin2
was analyzed to separate these populations of sorted cells
accordingly to the Wnt activity (Figure S5B). GFP+ and
GFP cells (fractions P5 and P6), which had the Wnt
pathway ‘‘on’’ and ‘‘off,’’ respectively, were analyzed for
the expression of pluripotency and for MET and senescent
genes. As expected, Axin2, CyclinD1, and BMP4 were more
expressed in the GFP+ cells than in GFP cells. The GFP
cells underwent efficient MET, as they upregulated Epcam
and Cdh1 and expressed low levels of Snai1, Vimentin,
and Slug with respect to GFP+ cells. Also, the senescent
gene p16 and p19 were downregulated in GFP cells.
Furthermore, the pluripotency markers Rex1, Nanog, Oct4,
and Sall1 were efficiently expressed in GFP cells (Fig-Figure 3. Time-Dependent Activation of Wnt/b-Catenin Pathway
(A) Experimental scheme of time course analysis of FACS-sorted cells.
days 3, 6, and 9, the cells were FACS-sorted for THY1-positive (THY1+;
analyzed.
(B) Time-dependent expression of MET and senescence markers. Rela
markers (Snai1, Slug, and Vimentin), and senescent markers (p21, p16
cells (n = 3 independent experiments).
(C) An equal number of THY1-positive (blue) and THY1-negative (red
induction. The number of reprogrammed clones was analyzed using N
(D) Expression of Tcf3 and Tcf1 was analyzed in sorted THY1-positive (b
at the indicated days after doxycycline induction (n = 3 independent
(E) Schematic representation of the two main TCF1 isoforms. TCF1FL
TCF1DN lacks this domain. Representative western blotting of four-fa
Extracts from ESCs and thymocytes were used as controls. Antibodie
were used.
(F) MEFs were infected with 7TGP reporter construct and induced wi
analyzed by GFP expression by FACS (n = 3 independent experiments
(G) Expression of Wnt/b-catenin target genes (Axin2, CyclinD1, and
negative (red) cells using quantitative real-time PCR at the indicated
(H) Representative western blot of active b-catenin in nuclear extr
doxycycline induction.
All pooled data are represented as means ± SD. The asterisks indicate s
also Figure S3.
Steure 5B). Finally, when replated and cultured in presence
of doxycycline, only GFP cells formed a very high number
of NANOG+ or AP+ clones, whereas GFP+ cells did not (Fig-
ures 5C, S5C, and S5D). We also analyzed GFP+ cells using
immunofluorescence and showed that these cells ex-
pressed Nestin (Figure 5D), which suggested they were
more differentiated. These results clearly indicate that in
the initial steps of the reprogramming process, i.e., up to
6 days after doxycycline induction, the Wnt ‘‘off’’ state is
a robust marker of reprogramming.
To further confirm these data, we treated four-factor
MEFs for different times with IWP2, an inhibitor of Wnt
secretion (Figure 5E) (ten Berge et al., 2011). IWP2 treat-
ment for the first 6 days decreased Tcf1 expression and
increased Tcf3 expression in the whole-cell population.
Along with its effects on Wnt secretion, this resulted in in-
hibition of the activation of theWnt/b-catenin pathway, as
demonstrated by the repression of Axin2 (Figure 5F).
Together with IWP2, doxycycline induction was applied
for 12 days, and the iPSC colonies were analyzed at day
16 (4 days after doxycycline removal) (Figure 5E). MEFs
treated with IWP2 for 6 days expressed high levels of
Nanog, Rex1, and endogenous Oct4 (Figure 5F). Further-
more, the number of iPSC colonies was strongly increased
when MEFs were treated for the first 3 or 6 days with
IWP2 (Figure 5G). In addition, the silencing of p21 after
IWP2 treatment for 6 days did not result in an increase of
reprogramming, further confirming that p21 is an impor-
tant effector of the Wnt pathway inhibition in the reprog-
ramming process (Figures S5E and S5F). In contrast,Controls Reprogramming of Four-Factor-Induced MEFs
Four-factor MEFs were induced with doxycycline as in Figure 2A. At
blue) and THY1-negative (THY1; red) expression (right panel) and
tive expression of epithelial markers (Epcam, Cdh1), mesenchymal
, and p19) in THY1-positive (blue) and THY1-negative (red) sorted
) cells were sorted and plated on feeders at day 6 after doxycycline
ANOG immunostaining (n = 3 independent experiments).
lue) and THY1-negative (red) cells using quantitative real-time PCR
experiments).
contains a N-terminal b-catenin binding domain (BCBD), whereas
ctor MEF extracts on day 0 and day 6 after doxycycline induction.
s against the total TCF1 isoforms and against the full-length TCF1
th doxycycline as in Figure 2A. At days 3, 6, and 9, the cells were
).
BMP4) were analyzed in sorted THY1-positive (blue) and THY1-
days after doxycycline induction (n = 3 independent experiments).
acts of THY1-positive and THY1-negative sorted cells 6 days after
tatistical significance by t test analysis (* p < 0.05; ** p < 0.01). See
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inhibition of the Wnt pathway with IWP2 strongly
reduced the reprogramming efficiency (Figure 5G). This
indicated that the pathway should be inhibited during
the first phase of reprogramming and should have a basal
activation level during the second phase of reprogram-
ming. To confirm these data, we transfected MEFs with
shTcf1 (Figure S5G). In this way, we obtained that shTcf1
was lost within 6 days after induction (Figure S5H), whereas
in the infected cells, the silencing was constant for all the
reprogramming process (Figures S5J and S5K). We found
that whereas the constant inhibition of Tcf1 resulted in a
decreased number of NANOG+ colonies (Figure 2B), Tcf1
transient inhibition resulted in increased efficiency of
reprogramming (Figure S5I).
Activation of the pathway by addingWnt3a early during
the reprogramming process inhibits its efficiency (Figures
5G and S5L), whereas the addition of Wnt3a late during
the reprogramming process only resulted in a slight
increase in the reprogramming efficiency (Figure 5G). In
addition, the combined inhibition and activation with
IWP2 andWnt3a during the early and late phases of reprog-
ramming, respectively, moderately increased the efficiency
of reprogramming as compared to early inhibition alone
(Figure 5G). This indicates that inhibition ofWnt signaling
in the early phase is essential and that a basal activation of
Wnt pathway is sufficient during late phases of the reprog-
ramming process (Figure 5G). Finally, we used two addi-
tional inhibitors of theWnt pathway to treat theMEFs dur-
ing early reprogramming phases: Dkk1, which acts as Wnt
ligand antagonist (Katoh and Katoh, 2007; Niida et al.,
2004), and ICRT3, which blocks the interaction between
b-catenin and T cell factors (Faunes et al., 2013; Gonsalves
et al., 2011). We further confirmed that early inhibition ofFigure 4. TCF1 Is a Repressor of Senescent and Mesenchymal dur
(A) Four-factor MEFs were infected with lentiviruses overexpressing eit
Four days after infection, the expression of Wnt/b-catenin pathway ta
senescence markers (p21, p19, and p16) were analyzed (n = 3 indepe
(B) Quantitative ChIP assay of the TCF1 targets Axin2, Snai1, and p2
noglobulin G or a specific antibody against TCF1 (n = 2 independent
(C) Four-factor MEFs were infected with lentivirus overexpressing FLT
days after doxycycline induction, cells were analyzed by THY1 expres
(D) Quantitative real-time PCR expression analysis of empty vector (EV
(n = 3 independent experiments).
(E) Experimental scheme: four-factor MEFs were infected and treated
after doxycycline induction, as indicated.
(F) The same number of THY1-negative cells was sorted at day 6 after
and plated on feeders. The number of NANOG+ clones was determined
(G) Quantitative real-time PCR expression analysis of shScr and shT
induction. The mesenchymal (Snai1),; epithelial (Cdh1, Epcam), an
experiments).
All pooled data are represented as means ± SD. The asterisks indicate s
also Figure S4.
Stethe pathway results in increased reprogramming efficiency
(Figure S5L). Overall, these findings showed that time-
dependent perturbation of the Wnt pathway is funda-
mental to enhance reprogramming efficiency.DISCUSSION
Earlier we showed that cyclic activation of the Wnt
signaling pathway is necessary to enhance cell-fusion-
mediated reprogramming (Lluis et al., 2008). Also, we
showed that finely tuned levels of the Wnt pathway are
essential for enhancing somatic cell reprogramming. Too
high or too low levels of b-catenin activity result in an
impaired reprogramming efficiency (Lluis et al., 2008).
Here, we demonstrate that, to achieve reprogramming,
Wnt signaling needs to be repressed during the early phase
of the process and to be active at the late steps; indeed, in a
recent interesting study, a similar conclusion was reached
(Ho et al., 2013). However, whereas Ho et al. studied prev-
alently the function of TCF3 in the regulation of reprog-
ramming and focused on the analysis of the whole MEFs
population, here we have extensively studied the function
of TCF1, demonstrating its essential role during the reprog-
ramming process. In addition, we have characterized the
activity of TCF1 in the THY-negative cells, which are the
cells that undergo reprogramming. We have shown that
TCF1 acts as a repressor of the Wnt signaling pathway at
the onset of reprogramming. Furthermore, it promotes
repression of senescent genes and activation of MET (by
inhibition of transcription of mesenchymal genes and by
activation of epidermal genes) in the THY-negative cells,
whereas TCF1 acts as an activator in the THY-positive cells
that do not undergo reprogramming.ing the First Days of Reprogramming
her FLTcf1 orDN-Tcf1. Infected cells were selected with hygromycin.
rget (Axin2), mesenchymal markers (Vimentin, Slug, and Snai1), and
ndent experiments). EV, empty vector control.
1 in the four-factor MEFs. ChIP was performed using rabbit immu-
experiments).
cf1 or with an empty vector (EV) and selected with hygromycin. Six
sion by FACS (n = 3 independent experiments).
) or FLTcf1-overexpressing cells at 6 days after doxycycline induction
as in Figure 2A. THY1-negative cells (THY1) were sorted at day 6
doxycycline induction of shScr or shTcf1A-infected four-factor MEFs
under each treatment (n = 3 independent experiments).
cf1A-infected, THY1, four-factor MEFs at day 6 after doxycycline
d senescence (p21, p16) genes are analyzed (n = 2 independent
tatistical significance by t test analysis (* p < 0.05; ** p < 0.01). See
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tive cells represent themajority of the total cell population;
therefore, the repressive activity of TCF1 in the THY-nega-
tive cells cannot be identified without isolating them.
Finally, by sorting the ‘‘Wnt-off’’ cells, we obtained a
striking increase in the number of reprogrammedNANOG+
clones, thus clearly identifying the ‘‘Wnt-off’’ state as an
early reprogramming marker.
It is interesting to note how different the roles of TCF3
and TCF1 are in the control of somatic cell reprogramming.
We showed previously that deletion of Tcf3 induces
increased AcH3 and a decreased number of H3K9me3
heterochromatin foci. These epigenomemodifications ulti-
mately enhance reprogramming efficiency (Lluis et al.,
2011). Here, we showed that the role of TCF1 during the
early reprogramming phase is correlated with the repres-
sion of senescence genes and with the activation of MET.
Ho et al. (2013) provided evidence that TCF3 and TCF4 pro-
mote early reprogramming events by repressing Wnt
pathway target genes, including TCF1 and LEF1. However,
they also postulated that TCF3 and TCF4 could control
other targets that are independent of TCF1 and LEF1 or of
theWnt pathway activation (Ho et al., 2013). It is tempting
to speculate that the latter mentioned might be
activated by the epigenetic modifications induced by Tcf3
derepression.
Very little is known about TCF1 activity in ESCs,
although it has been demonstrated that inmedium lacking
LIF, TCF1 contributes to the effect of Wnt3a stimulation to
ESC self-renewal (Yi et al., 2011). Here, we have revealed
that in medium containing LIF and serum, wild-type
ESCs and ESCs silenced for Tcf1 do not show differences
in self-renewal and differentiation, indicating that TCF1
does not control either process. TCF1 is instead a key regu-
lator of the reprogramming process. This led to the inter-Figure 5. Inhibition of the Wnt/b-Catenin Pathway during the Firs
Efficiency
(A) Four-factor MEFs were infected with lentiviruses carrying 7TGP r
induction. Doxycycline was removed at day 12, and colonies were an
(B) GFP+ and GFP cells were sorted 6 days pi and analyzed by quant
experiments).
(C) The number of NANOG-positive clones in GFP+- and GFP-sorted c
(D) GFP+ cells were FACS-sorted at day 6 pi, and cells were analyzed b
images of the immunofluorescence are shown. Scale bars, 100 mm.
(E) Experimental scheme: four-factor MEFs were treated with doxycy
indicated days. At day 16, after doxycycline removal, the colonies we
(F) Four-factor MEFs were treated with IWP2 for 6 days. Quantitati
experiments).
(G) The number of NANOG-positive clones in the control and four-fact
intervals from 6 to 12 or 8 to 12 days as indicated, Wnt3a for the first 4
combination of IWP2 and Wnt3a at the indicated times (n = 3 indepe
All pooled data are represented as means ± SD. The asterisks indicate
0.05; ** p < 0.01). See also Figure S5.
Steesting observation that some key transcription factors do
not always control both somatic cell reprogramming pro-
cesses and ESC self-renewal, as the effects on these two pro-
cesses can be distinct.
Both MET and the downregulation of senescence genes
are essential processes to achieve somatic cell reprogram-
ming (Esteban et al., 2012; Mahmoudi and Brunet, 2012).
Our data show that TCF1 is an important regulator of these
processes. Senescent cells are characterized by cell-cycle ar-
rest due to p16INK4a induction. Cell proliferation is crucial
in the reprogramming process, and thus cell-cycle arrest
is a major barrier to the efficiency of this process. Indeed,
mouse fibroblasts cannot be reprogrammed efficiently
when two antiproliferative genes, p16INK4a and p19ARF,
which are part of the lnk4/Arf locus, are highly expressed.
Accordingly, silencing of the lnk4/Arf locus restores reprog-
ramming efficiency in senescent cells. Furthermore, knock-
down of p53 and p21 also accelerates reprogramming of
human and mouse fibroblasts (Banito et al., 2009; Hong
et al., 2009; Kawamura et al., 2009; Li et al., 2009; Mario´n
et al., 2009; Utikal et al., 2009). Thus, senescence is a barrier
to the reprogramming activity, and this can be overcome
by TCF1 action, which maintains low expression of p21
and p19 during reprogramming.
DuringMET, SOX2,OCT4, andC-MYChave been shown
to supress Snai1 and TGF-b signaling, whereas KLF4 has
been shown to upregulate E-cadherin (Li et al., 2010; Sama-
varchi-Tehrani et al., 2010). Here, we found that TCF1
activity is correlated not only with repression of senescence
genes, but also with MET activation. Embryoid bodies
derived from ESCs undergo epithelial-to-mesenchymal
transition in a Wnt-dependent process, with the Wnt
activity inducing upregulation of Snai1 and repression of
E-cadherin (ten Berge et al., 2008). It is therefore in-
triguing that during reprogramming, TCF1 enhances METt Days of the Reprogramming Process Increases Reprogramming
eporter. GFP+ and GFP cells were sorted 6 days after doxycycline
alyzed at day 16.
itative real-time PCR for the indicated markers (n = 3 independent
ells at day 16 (n = 3 independent experiments).
y immunofluorescence for the expression of Nestin. Representative
cline for 12 days and with IWP2 to inhibit Wnt secretion for the
re stained for NANOG expression and counted.
ve real-time PCR of control and treated cells (n = 3 independent
or MEFs treated with IWP2 for the first 3, 4, 6, or 12 days or for the
or 12 days or for the intervals from 8 to 12 days as indicates, or with
ndent experiments).
statistical significance by t test analysis (n.s., not significant; * p <
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upregulating E-cadherin. Furthermore, we observed that
TCF1 directly represses Snai1 by binding to its promoter.
SNAI1 has been shown to be a transcriptional repressor of
E-cadherin (Batlle et al., 2000). Thus, it might well be
that E-cadherin is derepressed as a consequence of TCF1-
mediated repression of Snai1.
However, we cannot definitively conclude here what the
prevalent role of TCF1 is during reprogramming, i.e., if the
main function of TCF1 is to modulate senescence genes
and MET or also to activate other factors downstream of
the Wnt pathway. Finally, it will be particularly interesting
to investigate if theWnt ‘‘off’’ state mediated by the repres-
sive activity of TCF1 is one of the most efficient early
reprogramming markers.EXPERIMENTAL PROCEDURES
iPSC Induction
The reprogramming experiments were routinely conducted in
gelatinized plates, in the ESC culture medium supplemented
with 2 mg/ml doxycycline, as described in Carey et al. (2010).
Briefly, after doxycycline withdrawal, the cultures were grown in
the ESC medium supplemented with 15% FBS. Colonies with
ESC morphology were picked 4–6 days after doxycycline with-
drawal and grown as iPSC colonies on a feeder layer of MEFs that
was inactivated with mitomycin C.
Virus Preparation and MEF Infection
Lentiviruses were packaged in HEK293Tcells. Briefly, the HEK293T
cells were cultured in Dulbecco’s modified Eagle’s medium sup-
plied with 10% FBS (Life Technologies), 10 U/ml penicillin,
10 mg/ml streptomycin, 2 mM glutamine, 1 mM sodium pyruvate,
and 1 3 nonessential amino acids. For the transfection, 5 3 106
HEK293T cells were seeded onto 10 cm plates and transfected
with 10 mg pLKO-shTcf1A, pLKO-shTcf1B, or pLKO-shScr, 6.5 mg
pCMV-dR8.9 dvpr, and 3.5 mg pCMV-VSV-G packaging plasmids.
After 48 and 72 hr, the supernatants were collected and centrifuged
at 20,000 rpm for 1.5 hr at 20C. The pellet with the viruses was
resuspended in PBS (Life Technologies) and stored at 80C.
For the reprogramming experiments, 23 105MEFs were infected
with either pLKO-shTcf1A, pLKO-shTcf1B, or pLKO-shScr in
the MEF culture medium. After 48 hr, hygromycin selection
(20 mg/ml) was applied for 3–4 days. For iPSC induction, the cells
were then plated in equal numbers (5 3 104) onto gelatin-coated
six-well plates in the ESC culture medium supplemented with
2 mg/ml of doxycycline.
All animal procedures were approved by the local ethics commit-
tee, and met the guidelines of the local and European regulations.
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